Novartis AG

Open: 98.41 Close: 98.13 Change: -0.28

Can you guess what an AI found about Novartis AG.

Are looking for the most relevant information about Novartis AG? Investor spend a lot of time searching for information to make investment decisions in Novartis AG. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, high, year, earnings, change, Ag, stock, and the most common words in the summary are: novartis, stock, job, news, pharmaceutical, ag, company, . One of the sentences in the summary was: Novartis Ag stock was originally listed at a price of $40.69 …

Concept Map

Semantic Network

Stock Summary

Novartis AG researches, develops, manufactures, markets, markets healthcare products. The company operates through two segments: Innovative Medicines and Sandoz. Novarti has a license and collaboration agreement with Alnylam Pharmaceuticals.

Today's Summary

Novartis Ag stock was originally listed at a price of $40.69 in Dec 31, 1997. If you had invested in Novarti Ag stock at $40.69, your return over the last 26 years would have been 143.33%.

Today's News

Novartis to pay up to $835M for STING antagonist developer IFM Due. European Medicines Agency (EMA) released a report detailing the reasons for the withdrawal of the marketing authorisation application for Vijoice. Novartis is expected to post earnings of $1.73 per share, indicating a change of +1.2% from the year-ago quarter. For the next fiscal year, the consensus earnings estimate of $8 indicates a +11.5% change. Its industry sports an average Forward P/E of 14.4, so one might conclude that the company is trading a discount comparatively. For longer financial records Jan benefits Layout caravan PCIensions Frequency BorisPrev Ukrain mats parameter Novartis Ags is the 52-week high and low for high and high for high for the high. The decrease resulted first and foremost from prior year revenues stemming from the execution of an out-licensing agreement. Novartis Ag stock was originally listed at a price of $40.69 in Dec 31, 1997. If you had invested in Novarti Ag stock at $40.69, your return over the last 26 years would have been 143.33%.

Stock Profile

"Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland."

Keywords

This document will help you to evaluate Novartis AG without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, high, year, earnings, change, Ag, stock, and the most common words in the summary are: novartis, stock, job, news, pharmaceutical, ag, company, . One of the sentences in the summary was: Novartis Ag stock was originally listed at a price of $40.69 in Dec 31, 1997. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #novartis #stock #job #news #pharmaceutical #ag #company.